Long-term follow-up of genicular artery embolization for knee osteoarthritis
Tracks pain and safety after genicular artery embolization in adults with knee osteoarthritis.
Key facts
- Who runs it
- Joint & Vascular Institute
- Where
- Libertyville, United StatesSee the site
- Trial code
- Registry title
- geniculaR Artery eMBolization for Knee Osteoarthritis (RAMBO) Registry
- Status
- Recruiting
- People taking part
- 1,200 people, planned
- Started
- 16 Jul 2025
- Expected to end
- Jul 2030
- Type of study
- Observational
- Treatments tested
- Genicular Artery Embolization
- Record updated
- 12 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with knee osteoarthritis that causes symptoms and has not improved with medical therapy. They must be referred for genicular artery embolization (GAE), a procedure that blocks small blood vessels around the knee.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Knee osteoarthritis that causes symptoms
- Earlier treatment
- Medical therapy was tried and did not help enough
Main reasons for not taking part
- Pregnancy
- Blood clotting problems (coagulopathy)
- Severe other illnesses
- Not able to give consent
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Adults (≥18 years) with symptomatic KOA refractory to medical therapy, referred for GAE
Who cannot take part
- Pregnancy, coagulopathy, severe comorbidities, or inability to consent
Where in United States
- Joint and Vascular InstituteLibertyville, United StatesContact: Layth AlkhaniTaking people
About the trial
What the trial wants to find out
The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of genicular artery embolization (GAE) for knee osteoarthritis in adults aged 18 years or older with symptomatic KOA that has not responded to medical therapy.
Read full original descriptionShow less
The main questions it aims to answer are:
1. Does GAE lead to sustained improvement in pain (WOMAC, VAS) and quality-of-life scores over 12-36 months? 2. What patient or procedural factors are associated with better outcomes after GAE?
Participants will:
* Undergo GAE as part of their routine clinical care. * Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires. * Have safety outcomes tracked according to Society of Interventional Radiology guidelines.
There is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.
Treatments tested
- Genicular Artery Embolization
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Creation Of a Prospective Registry For Genicular Artery Embolization At The Joint & Vascular Institute
- Plain-language title
- Long-term follow-up of genicular artery embolization for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 12 June 2026